Insmed Inc (INSM) News Headlines

▮ More

Date

Headline

5/5/2023 8:02:52 AM Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

5/4/2023 7:46:26 AM Insmed Q1 Total Revenue $65.2 Mln, 23% Year-over-year Growth

3/31/2023 8:00:00 AM Insmed Completes Enrollment of Adult Patients in Phase 3 ASPEN Study of Brensocatib in Bronchiectasis (Press Release)

2/23/2023 7:42:35 AM Insmed Q4 Net Loss Widens To $160 Mln From $112.9 Mln Last Year

12/12/2022 7:49:46 AM Pre-market Movers: APVO, ACET, COUP, AMAM, CJJD…

11/4/2022 8:13:48 AM Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

10/28/2022 9:36:23 AM ALNY Reiterates Guidance, TVTX Loss Widens, DXCM Paints Rosy Outlook

10/27/2022 7:32:07 AM Insmed Inc. Q3 Net Loss $131.1 Mln Vs. Net Loss $112.7 Mln Last Year

10/7/2022 8:06:48 AM Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

10/7/2022 8:00:00 AM Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (Press Release)

9/7/2022 8:00:00 AM Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (Press Release)

8/4/2022 7:41:09 AM Insmed Q2 Net Loss $95.6 Mln Or $0.80/shr Vs. Net Loss $117.3 Mln Or $1.07/shr Last Year

8/4/2022 7:30:00 AM Insmed Reports Second Quarter 2022 Financial Results and Provides Business Update (Press Release)

7/8/2022 8:01:12 AM Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

7/8/2022 8:00:00 AM Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (Press Release)

4/7/2022 8:02:41 AM Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

3/4/2022 8:01:53 AM Insmed Announces Inducement Grants Under NASDAQ Listing Rule

2/17/2022 7:11:41 AM Insmed Q4 Net Loss $113 Mln Vs. Net Loss $102.2 Mln Last Year

10/28/2021 7:40:02 AM Insmed Q3 Total Revenue $46.8 Mln Vs. $43.6 Mln Prior Year

10/5/2021 8:08:35 AM Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)